When was Axio founded?

Axio was founded in 2008 and raised its 1st funding round 2 years after it was founded.

Where is Axio located?

Axio is headquartered in Ahmedabad, India. It is registered at PLOT NO 18, GUJARAT PHARMA TECHNO PARK SARI-MOTODA, TA: SANAND, Ahmedabad, AHMEDABAD, Gujarat, India, 382220.

Who is the current CEO of Axio?

Leo Mavely of Axio. They have also founded 2 companies.

Which legal entities is Axio associated with?

Axio is associated with AXIO BIOSOLUTIONS PRIVATE LIMITED.

How many employees does Axio have?

As of Aug 31, 2025, Axio has 75 employees, reflecting a 9% year-over-year growth in headcount.

Is Axio a funded company?

Axio is a funded company, having raised a total of $20.5M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2010.

How much is Axio worth?

The latest valuation of Axio is $***** as of Feb 25, 2015.

When was the latest funding round of Axio?

Axio's latest funding was a $***** Series B round on Jul 27, 2021, with participation from 4 investors. Its primary sector is Wound Care. Globally, the Wound Care sector has seen $29.9M in funding in 2026 to date.

What is the annual revenue of Axio?

Annual revenue of Axio is ₹19.9Cr as on Mar 31, 2024.

Where does Axio rank among its competitors?

Axio ranks 2nd amongst 141 active competitors, of which 21 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Cresilon, which secured $5M in Apr, 2026.

Who are the top competitors of Axio?

Axio's top competitors include Imbed Biosciences, Kane Biotech and Cresilon. Among them, Cresilon secured the most recent funding round in April, 2026.

Axio - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of advanced haemostat and wound care dressing products. The company provides solutions for bleeding control during surgical procedures and trauma events. It offers wound care dressings designed for effective management of various wound types. The products utilize biomaterials and technologies focused on haemostasis and wound healing.

Website: axiobio.com
Social
Email ID: *****@axiobio.com
Phone Number: +91 **********
Part Of
Registered Address: PLOT NO 18, GUJARAT PHARMA TECHNO PARK SARI-MOTODA, TA: SANAND, Ahmedabad, AHMEDABAD, Gujarat, India, 382220

Key Metrics

Founded Year

2008

Location

Ahmedabad, India

Stage

Series B

Total Funding

$20.5M in 6 rounds

Latest Funding Round

Series B, Jul 27, 2021, $*****

Post Money Valuation

$***** as on Feb 25, 2015

Investors

RNT Capital Advisers & 13 more

Ranked

2^nd among 141 active competitors

Annual Revenue

₹19.9Cr as on Mar 31, 2024

Employee Count

75 as on Aug 31, 2025

Similar Companies

Imbed Biosciences & 22 more

View Axio's full profile

Axio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
AXIO BIOSOLUTIONS PRIVATE LIMITED CIN: U73100GJ2008PTC053905 , India, Active	May 16, 2008	$2.4M (As on Mar 31, 2024)	75 (As on Aug 01, 2025)

Axio has raised a total funding of $20.5M over 6 rounds. Its first funding round was on 2010. Its latest funding round was a Series B round on Jul 27, 2021 for $*****. 4 investors participated in its latest round. Axio has 13 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Axio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 27, 2021	8035931	Series B	7434137	6593260	9697010	3032299
Jan 09, 2020	7072972	Series B	9194085	2498493	4366691	Accel & 2 more
Jan 26, 2018	3495049	Series B	1577079	1533387	Ratan N Tata & 1 more	Accel & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Axio's funding rounds and investors

The founders of Axio is Leo Mavely. Leo Mavely is the CEO of Axio.

Here are the details of Axio's key team members:

Leo Mavely: Founder & CEO of Axio and founder of 1 other company. They serve on the board of 1 company.

Axio's Board of Directors

Axio's board has 2 active members. Leo Mavely and Gourav Jagdishchandra Maheshwari are part of team.

Here is the list of Axio's board of directors:

Name	Type	Representing	Status	Duration
Leo Mavely	Team	-	Current	17y 11m
sanrybt	Team	-	Current	8y 1m

View details of Axio's Founder profiles and Board Members

Axio's employee count trend

Axio has 75 employees as of Aug 25. The total employee count is 9.0% more than what it was in Aug 24. Here is Axio's employee count trend over the years:

Uncover Axio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Axio include Imbed Biosciences, Kane Biotech and Cresilon. Here is the list of Top 10 competitors of Axio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Imbed Biosciences 2010, Madison (United States), Series C	Provider of nanotech-based wound care products	$34.3M	Niterra, MassChallenge & 7 others	68/100
2nd	Axio 2008, Ahmedabad (India), Series B	Developer of advanced haemostat and wound care dressing products	$20.5M	Accel, Gujarat Venture Finance & 12 others	58/100
3rd	Kane Biotech 2001, Winnipeg (Canada), Public	Developer of therapeutic solutions to prevent and remove biofilms	-	Canadian Space Agency, Genesys Venture & 2 others	58/100
4th	Cresilon 2010, New York City (United States), Series B	Developer of hemostatic products for wound care	$118M	Paulson Investment, Innovating Capital & 6 others	58/100
5th	Nuo Therapeutics 2001, Gaithersburg (United States), Public	Developer of regenerative products for wound care	$69.1M	MidCap Financial, Maryland Department of Commerce ... & 2 others	48/100
6th	NuVision 2015, Nottingham (United Kingdom), Public	Developer of an ophthalmic therapies for ocular surface disease	$13.4M	Mercia, Nottingham Technology Ventures & 35 others	58/100
7th	Acera Surgical 2013, St. Louis (United States), Acquired	Provider of synthetic electrospun scaffolds for regenerative medical applications	$6.32M	St. Louis Arch Angels, Missouri Technology ... & 1 others	57/100
8th	Alafair Biosciences 2011, Austin (United States), Series B	Biomaterials and biomedical devices that enhance internal wound healing	$13.7M	ATP, Austin Technology Incubator & 4 others	56/100
9th	Lohmann & Rauscher 1998, Rengsdorf (Germany), Funding Raised	Dressing materials and medical devices	-	Austria Wirtschaftsservice, Gov.cz	56/100
10th	Regenics 2005, Oslo (Norway), Public	Developer of marine-ingredient based wound care products	-	-	48/100